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Abstract
Background
We hypothesized that obstructive sleep apnea (OSA) can predispose individuals to lower
airway infections and community-acquired pneumonia (CAP) due to upper airway microas-
piration. This study evaluated the association between OSA and CAP.
Methods
We performed a case-control study that included 82 patients with CAP and 41 patients with
other infections (control group). The controls were matched according to age, sex and body
mass index (BMI). A respiratory polygraph (RP) was performed upon admission for patients
in both groups. The severity of pneumonia was assessed according to the Pneumonia
Severity Index (PSI). The associations between CAP and the Epworth Sleepiness Scale
(ESS), OSA, OSA severity and other sleep-related variables were evaluated using logistic
regression models. The associations between OSA, OSA severity with CAP severity were
evaluated with linear regression models and non-parametric tests.
Findings
No significant differences were found between CAP and control patients regarding anthro-
pometric variables, toxic habits and risk factors for CAP. Patients with OSA, defined as indi-
viduals with an Apnea-Hypopnea Index (AHI)10, showed an increased risk of CAP (OR =
286, 95%CI 129–644, p = 001). Patients with severe OSA (AHI30) also had a higher
risk of CAP (OR = 318, 95%CI 111–1156, p = 0047). In addition, OSA severity, defined
according to the AHI quartile, was also significantly associated with CAP (p = 0007). Fur-
thermore, OSA was significantly associated with CAP severity (p = 00002), and OSA sever-
ity was also associated with CAP severity (p = 00006).
Conclusions
OSA and OSA severity are associated with CAP when compared to patients admitted to the
hospital for non-respiratory infections. In addition, OSA and OSA severity are associated
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with CAP severity. These results support the potential role of OSA in the pathogenesis of
CAP and could have clinical implications. This link between OSA and infection risk should
be explored to investigate the relationships among gastroesophageal reflux, silent aspira-




Obstructive sleep apnea (OSA) is a highly prevalent disorder affecting between 10–50% of mid-
dle-aged men [1]. OSA is characterized by recurrent upper airway obstruction associated with
cyclic changes in oxyhemoglobin saturation, intermittent arousals from sleep and alterations in
intrathoracic pressure. These alterations induce oxidative stress, sympathetic activation, and
metabolic dysregulation [2]. OSA is also related to the increased incidence of hypertension,
cardiovascular events [3,4] and cancer [5].
A small amount of silent aspiration during the night is normal in healthy individuals [6]. How-
ever, OSA can predispose an individual to increased aspiration [7]. OSA is characterized by alter-
ations in the intrathoracic pressure and by a weak or absent cough reflex, mainly during rapid eye
movement (REM) sleep [8,9] These alterations may be due to the action of cortical inhibitory
nerves to the brainstem cough center and an increased threshold of peripheral nerves at night.
Gastroesophageal reflux (GER) is frequently associated with OSA [10,11], and previous studies
have suggested a possible association between OSA and respiratory disorders, such as cough, pneu-
monia, asthma or laryngitis [12,13]. Furthermore, treatment of GER produces small but significant
reductions in the apnea hypopnea index (AHI) [14,15], and studies have demonstrated that many
patients who do not respond to anti-reflux therapies experience sleep-disordered breathing [10].
Four recent studies, one involving children<5 years of age [16] and three national surveys
among adults [17–19], have suggested that OSA could increase the incidence of pneumonia.
To address this question, we designed a case-control study to compare the prevalence of OSA
among patients with community-acquired pneumonia (CAP) with respect to patients with
other non-respiratory infections. To our knowledge, this report is the first evaluation of the
risk of CAP in OSA patients.
Methods
Study design
A case-control study was performed at the University Hospital of San Juan de Alicante, Spain,
from 2012 to 2014. Cases were defined as patients admitted to the hospital with a diagnosis of
CAP. Controls were defined as patients admitted to the Departments of Internal Medicine,
Infectious Diseases or Traumatology for other infectious diseases not related to the respiratory
tract. Patients with infections were included in both groups (cases and controls) to ensure that
these groups were as similar as possible. The presence of infection, regardless of an infection’s
origin, implies an increase in systemic inflammatory activity. This inflammation could be
related to the presence of OSA. Patients with suspected bronchogenic carcinoma, human
immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS),
severe acute cardiorespiratory comorbidity, nosocomial pneumonia, neurological deficits,
other sleep disorders (dyssomnias or parasomnias), patients previously diagnosed of OSA,
Pneumonia and Obstructive Sleep Apnea
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CPAP treatment, use of hypnotics or sedatives and those without informed consent were
excluded. Clinical interviews were used to exclude patients with other sleep disorders. In addi-
tion, for controls, patients with infections of the ear, nose and throat (ENT), such as rhinosinu-
sitis, tonsillitis or otitis, were also excluded. Cases and controls were matched at a 2:1 ratio
according to age, sex and body mass index (BMI); in particular, pairs of cases with similarities
in age, sex and BMI (minimizing the differences within pairs) were first established, and a
matched control was then selected.
Primary association: OSA as a risk factor for pneumonia
OSA and OSA severity were assessed as risk factors for the presence of CAP according to differ-
ent thresholds in the AHI scale (AHI10 vs. AHI<10, AHI30 vs. AHI<30 and AHI quar-
tiles). The associations between the Epworth Sleepiness Scale (ESS), other sleep-related
variables with CAP were also assessed.
Secondary association: OSA and pneumonia severity
The associations between OSA, and OSA severity with pneumonia severity were assessed
according to different thresholds in the AHI scale (AHI10 vs. AHI<10, AHI30 vs. AHI
<30 and AHI quartiles). The severity of pneumonia was defined by the pneumonia severity
index (PSI) [20]. This association was specifically assessed for CAP cases.
Protocol and procedures
Patients with CAP were evaluated within the first 48 hours after hospitalization. Specific sleep
questionnaires were used to evaluate symptoms related to OSA. Daytime sleepiness was evaluated
with the ESS [21]. Demographic aspects, toxic habits (smoking, ex-smoking, alcohol habit), and
comorbidities (COPD, diabetes, oral or inhaled steroids during the last 6 months, previous pneu-
monia, asthma, heart failure, kidney failure, hospitalization during the previous 3 months, cerebro-
vascular disease, lung neoplasms, extrapulmonary neoplasms and bronchiectasis) were assessed.
Physical examinations were conducted, including weight, height and the Mallampati scale.
CAP was defined as the presence of an infiltrate (observed via a chest X-ray) and an acute
illness associated with one or more of the following signs and symptoms: new cough with or
without sputum production, pleuritic chest pain, dyspnea, fever, hypothermia, altered breath
sounds on auscultation or leukocytosis [22]. The CAP admission criteria were based on the
Spanish guidelines [23]. CAP assessment included a blood analysis, arterial blood gases and
quantitative cultures from sputum or bronchial-protected samples obtained by fiberoptic bron-
choscopy. The etiological diagnosis was investigated in all cases.
A validated recording device system was used to measure respiratory disturbance during sleep
in patients and controls (Stardust1, Respironics, Murrisville, CA, USA) [24]. Scoring was per-
formed manually by researchers blinded to the allocation of patients into groups. The AHI scale
was defined as the number of apneas + hypopneas divided by the number of hours in bed or
recording time. The minimum recording time was 6 hours, and the minimum time for valid
analysis was 240 minutes. Oximetric parameters were also obtained from oximetry tracings,
including the baseline oxygen saturation (SpO2 basal), medium oxygen saturation (SpO2 med),
minimum oxygen saturation (SpO2 min) and percentages below saturation between different
intervals as a percentage of total time with O2 saturation<90% (Tsat90). An AHI value10 was
considered to be diagnostic for OSA, and AHI30 was considered to represent severe OSA. The
OSA threshold of AHI10/h was chosen based on a cutoff with good sensitivity and specificity
in ROC curves. In particular, S = 74% and E = 100% for an AHI of 15/h in polysomnography;
this value was based on previous work and corresponded to significant OSA [25].
Pneumonia and Obstructive Sleep Apnea
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A respiratory polygraph (RP) was performed on supplemental oxygen as needed (38 cases,
47%) based on each patient’s medical condition. In patients with CAP, the sleep study was
repeated at home 1 month later.
Ethical aspects
The study was approved by the Ethics and Clinical Trials Committee of the San Juan University
Hospital, Alicante, Spain (05/104-1) in 2010, and written informed consent was obtained from
all patients before inclusion. The study began in 2012 and was completed in 2014. This study is
registered at the clinical trials registry (www.clinicaltrials.gov) with the number NCT01071421.
The authors confirm that all ongoing and related trials for this intervention are registered.
Statistical analyses
Means (and standard errors) and absolute frequencies (and percentages) were used to describe
the quantitative and qualitative variables, respectively. First, we compared the baseline vari-
ables between CAP cases and controls using the Mann-Whitney or Fisher test. The intra-class
correlation coefficient (ICC) was computed to assess the concordance between sleep measure-
ments during hospitalization and at home, and the 95% confidence intervals (CIs) were
obtained. Second, the association between the ESS, OSA, OSA severity (AHI and the AHI quar-
tiles considered on quantitative scales), and other sleep-related variables with the risk of CAP
was assessed. For this purpose, logistic regression models were used to estimate the differences
in CAP risk and calculate the odds ratios (OR), corresponding 95% CIs and p-values. A trend
test was also performed to specifically evaluate the association of OSA severity (according to
AHI quartiles) with CAP risk based on the logistic regression model. Finally, a specific analysis
was performed to assess the association between OSA, OSA severity and CAP severity (with
PSI as the quantitative scale). Thus, the Mann-Whitney and Kruskal-Wallis tests were used to
compare the PSI levels among the different groups based on AHI thresholds (10,30 and
quartiles). A linear regression model was used to evaluate the increased severity in PSI levels
according to the AHI quartiles. In addition, a Pearson correlation index was calculated to eval-
uate the linear relationship between AHI and PSI, and a Spearman test was used to assess sig-
nificance. All analyses were performed using the R statistical package (version 321, 2015,
http://www.R-project.org/) and the threshold for significance was set at 5% (α = 005). The
results described in the text are mainly supported by tables indicating the results obtained
using the statistical methods described above. Certain figures that emphasize significant effects
and contribute to visualizing the sizes of these effects are also provided.
Sample size and statistical power
We determined that the inclusion of 82 CAP cases and 41 controls would be required to
achieve 80% statistical power (β = 02) and detect a significant difference (OR at least 25 units)
to assess the association between cases and controls with pneumonia risk (assuming a preva-
lence of OSA in the control group of 40%). Using for this purpose a one-sided Z test based on
two proportions, and setting the significance level at 5% (α = 005).
Results
Patients
Fig 1 shows the flowchart for the study participants according to the STROBE (Strengthening
the Reporting of Observational Studies in Epidemiology) recommendations for case-control
epidemiological studies.
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In total, 82 CAP cases were included in the study. Therefore, 41 control patients who were
admitted to the hospital for various non-respiratory infections were selected. Cases and con-
trols (in a 2:1 ratio) were matched according to age, sex and BMI. The severity of pneumonia,
invasive diagnostic techniques used and bacterial etiology for the patients in the CAP group
are described in Table 1.
The different infection diagnoses for the patients in the control group are described in
Table 2.
Concordance between sleep respiratory measurements obtained during
hospitalization and at home
Acceptable correlations between sleep respiratory measurements acquired during hospitaliza-
tion and at home were observed for AHI, AI (apnea index), mean SaO2 and minimum SaO2
(ICCs of 0.41, 0.45, 0.39 and 0.36, respectively) (Table 3). The HI (hypopnea index), oxygen
desaturation index (ODI) and time spent with SaO2< 90% (TC90) were slightly higher at
home, but this difference was not significant.
Homogeneity of cases and controls
No significant differences were found between CAP and control patients regarding sex, age
and BMI (Table 4). No significant differences were found between CAP and control patients
regarding other baseline anthropometric variables, toxic habits and risk factors for CAP.
Therefore, both groups were clinically homogeneous (controlling for potentially confounding
variables and risk factors).
Fig 1. Study flowchart depicting recruitment.
doi:10.1371/journal.pone.0152749.g001
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Table 1. Baseline clinical characteristics, invasive diagnostic techniques and bacterial etiology in the
CAP group.
CAP cases (n = 82)
PSI score, mean 75.94 (30.71)
Class I-III 57 (69.51%)
Class IV 21 (25.61%)
Class V 4 (4.88%)
Invasive diagnostic techniques
Fiberoptic bronchoscopy samples 34 (41.46%)
Thoracocentesis 5 (6.10%)
Other 43 (52.44%)
Etiological diagnosisa 39 (47.56%)
Streptococcus pneumoniae 15 (38.46%)
Mycoplasma pneumoniae 7 (17.95%)
Pseudomonas aeruginosa 4 (10.26%)
Legionella pneumophila 3 (7.69%)
Staphylococcus aureus 3 (7.69%)
Streptococcus viridans 1 (2.56%)
Coxiella burnetti 1 (2.56%)
Escherichia coli 1 (2.56%)
Chlamydia pneumoniae 1 (2.56%)
Streptococcus oralis 1 (2.56%)
Streptococcus salivarius 1 (2.56%)
Streptococcus sanguis 1 (2.56%)
Mean Hospital stay, days 7.67± 3.7
Admission in ICU 3 (3.66%)
Data are presented as means (standard deviations) or frequencies (percentages).
a Six patients presented with more than one diagnosis. The percentage for each diagnosis was calculated
with respect to the total number of diagnoses (n = 39).
doi:10.1371/journal.pone.0152749.t001
Table 2. Diagnoses in the control group.
Controls (n = 41)
Diagnosis
Urinary tract infection 7 (17.07%)
Acute pyelonephritis 7 (17.07%)
Acute gastroenteritis 5 (12.20%)
Cellulitis of the extremities 5 (12.20%)
Fever of unknown origin 4 (9.76%)
Urinary sepsis 3 (7%)
Prostatitis 2 (4.88%)
Botulism 2 (4.88%)
Lymph node tuberculosis 1 (2.44%)
Cholecystitis 1 (2.44%)
Liver abscess 1 (2.44%)
Biliary sepsis 1 (2.44%)
Prosthetic knee infection 1 (2.44%)
Osteomyelitis 1 (2.44%)
Frequencies and percentages are shown for each infection.
doi:10.1371/journal.pone.0152749.t002
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Association of OSA and OSA severity with CAP
No significant differences were found in the sleepiness levels measured with the Epworth ques-
tionnaire between groups (Table 5). Patients with OSA, defined as AHI10, had a significant
286-fold increase in the risk of CAP, p = 001 (Table 5 and Fig 2A). Patients with severe OSA,
Table 3. Concordance analysis for the sleep respiratory measurements obtained during hospitalization and at home for CAP patients.
CAP cases (n = 82) Intra-class correlation coefﬁcient
During admission (n = 82) At home (n = 56)*
Apnea-hypopnea index (h-1) 19.07 (13.68) 23.94 (17.46) 0.41 (0.16,0.59)
Apnea index 14.06 (12.59) 17.87 (15.17) 0.45 (0.21,0.62)
Hypopnea index 4.88 (5.71) 6.02 (7.28) 0.05 (-0.28,0.31)
ODI 12.88 (11.96) 16.69 (14.48) 0.28 (-0.01,0.49)
Mean SaO2(%) 93.81 (3.16) 93.7 (2.92) 0.39 (0.13,0.58)
Minimum SaO2(%) 81.15 (9.4) 80.18 (9.64) 0.36 (0.08,0.55)
Tsat90 10.39 (21.07) 8.19 (17.41) 0.17 (-0.14,0.41)
Means (and standard deviations) for each measurement recorded during admission and at home are shown. Intra-class correlation coefﬁcients and 95%
CIs are shown.
* The home study could not be performed in 26 patients: 14 refused, 5 cited social problems, 3 were invalid, 2 moved to a different house and 2 died in
the intensive care unit.
doi:10.1371/journal.pone.0152749.t003
Table 4. Differences between patients with CAP and patients with other infections (controls): baseline anthropometric variables, toxic habits and
risk factors for CAP.
Total (n = 123) Control (n = 41) CAP (n = 82) p-value
Age 6127 (1886) 5861 (1796) 6260 (1926) 022
Sex (Men) 56 (4553%) 18 (439%) 38 (4634%) 085
Body mass index 2670 (420) 2642 (473) 2684 (394) 039
Neck circumference 3984 (316) 3968 (350) 3991 (300) 095
Smoking 022
Non-smoker 60 (4878%) 23 (561%) 37 (4512%)
Former-smoker 26 (2114%) 5 (122%) 21 (2561%)
Smoker 37 (3008%) 13 (3171%) 24 (2927%)
Alcohol intake > 40 g/day 27 (2195%) 8 (1951%) 19 (2317%) 082
COPD 21 (1707%) 4 (976%) 17 (2073%) 02
Asthma 11 (894%) 1 (244%) 10 (122%) 01
Bronchiectasis 7 (569%) 0 (0%) 7 (854%) 009
Previous pneumonia 12 (976%) 1 (244%) 11 (1341%) 006
Chronic heart failure 8 (65%) 1 (244%) 7 (854%) 027
Diabetes mellitus 20 (1626%) 7 (1707%) 13 (1585%) 1
Chronic renal failure 6 (488%) 0 (0%) 6 (732%) 018
Neoplasm 4 (325%) 3 (732%) 1 (122%) 011
Cerebrovascular diseases 5 (407%) 0 (0%) 5 (61%) 017
Steroid treatment 13 (1057%) 1 (244%) 12 (1463%) 006
Admission in 3 month previous 9 (732%) 3 (732%) 6 (732%) 1
Comorbidity* 90 (73.2%) 27 (65.9%) 63 (76.8%) 0.2
Data are presented as the means (and standard deviations) and absolute frequencies (and percentages) for quantitative and qualitative variables,
respectively. P-values were obtained with Mann-Whitney U tests or Fisher’s exact tests to assess the differences between cases and controls.
*Patients with at least 1 comorbidity described in the table.
doi:10.1371/journal.pone.0152749.t004
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defined as AHI30, had a significant 318-fold increase in the risk of CAP (Table 5). In addi-
tion, AHI levels were significantly higher in CAP patients (Table 5). OSA severity, defined by
the AHI quartile, was significantly associated with CAP (ORs 106, 3 and 365 for Q2, Q3 and
Q4, respectively, using Q1 as the reference, p = 0007, Table 5, Fig 2B). Furthermore, all indices
of oxygen saturation were significantly worse in the CAP group (Table 5).
Association of OSA and OSA severity with CAP severity
Specific analysis of the 82 CAP patients revealed that OSA was significantly associated with CAP
severity (PSI means 8395 ± 2630 and 4937 ± 2983 in patients with AHI10 and AHI<10,
respectively, p = 00002, Table 6 and Fig 3A). In addition, OSA severity was clearly associated
with pneumonia severity. Indeed, the AHI levels were significantly and positively correlated with
the PSI levels (Pearson correlation r = 043, p<000001, and the mean PSI levels were increased
according to the different OSA grades (PSI means 4800 ± 3066, 6724 ± 2556, 8696 ± 2386
and 8916 ± 2649, respectively in the AHI quartiles, p<000001, Table 6 and Fig 3B).
Discussion
The presence of OSA almost triples the risk of CAP, and this increased risk is related to the
severity of OSA. Additionally, CAP severity is related to OSA severity. These findings suggest
that OSA could be related to the pathogenesis of CAP.
There is a paucity of studies on the relationship of OSA and lung infections, although recent
studies have addressed this issue. Goldbart et al. showed that a previous diagnosis of OSA was
Table 5. Associations of ESS, OSA, OSA severity, and other sleep-respiratory variables with CAP.
Total (n = 123) Control (n = 41) CAP (n = 82) OR (95% CI) p-value
Epworth Sleepiness Scale 639 (348) 680 (303) 620 (369) 0951 (0852;1061) 037
OSA
AHI <10 (non-OSA) 38 (3089%) 19 (4634%) 19 (2317%) 1
AHI>10 (OSA) 85 (6911%) 22 (5366%) 63 (7683%) 2864 (1291;644) 001
AHI<30 98 (7967%) 37 (9024%) 61 (7439%) 1
AHI >30 (severe OSA) 25 (2033%) 4 (976%) 21 (2561%) 3184 (1108;11556) 0047
OSA severity
AHI, quantitative scale 1907 (1368) 1481 (1141) 2120 (1427) 1042 (1009;108) 002
AHI, quartiles
Q1 (AHI 0–92) 30 (2439%) 14 (3415%) 16 (1951%) 1
Q2 (AHI 93–141) 31 (252%) 14 (3415%) 17 (2073%) 1063 (0386;2929) 091
Q3 (AHI 142–275) 31 (252%) 7 (1707%) 24 (2927%) 3 (1018;9498) 0052
Q4 (AHI 276 or higher) 31 (252%) 6 (1463%) 25 (3049%) 3646 (1203;12169) 003
Trend p-value = 0007
Other sleep-related variables:
ODI 1288 (1196) 956 (902) 1454 (1291) 1043 (1006;1088) 003
Mean SaO2 9381 (316) 9473 (182) 9335 (357) 0852 (0733;0973) 003
Minimum SaO2 8115 (940) 8378 (766) 7984 (994) 0948 (0899;0992) 003
TC90, % 1039 (2107) 236 (651) 1441 (2447) 1065 (1022;1144) 002
Two AHI-based thresholds (above 10 or 30) and AHI quartiles were used to assess the association of OSA severity with CAP. Data are presented as the
means (and standard deviations) and absolute frequencies (and percentages) for quantitative and qualitative variables, respectively. Logistic regression
models were used to assess the differences in CAP risk. The ORs, corresponding 95% CIs and p-values were calculated. P-values from a trend test to
assess the association between OSA severity and CAP are also shown.
doi:10.1371/journal.pone.0152749.t005
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more common in children<5 years with pneumonia compared to children without pneumo-
nia [16]. Su et al. observed a 12-fold increase in the incidence of pneumonia in adult patients
with OSA (from the Taiwan National Health Insurance Research Database) [17]. Lindenauer
et al. carried out a retrospective cohort study of patients with pneumonia at 347 US hospitals,
including a total of 250,907 patients, showing that OSA is associated with higher rates of
mechanical ventilation, increased risk of clinical deterioration, higher resource use, and a mod-
estly lower risk of inpatient mortality [18]. Jean et al. carried out a retrospective study in 74,032
patients with pneumonia and invasive mechanical ventilation, showing that OSA patients had
a significantly shorter hospital stay and a reduced risk of mortality. However [19], the lack of
individual data and the potential confounding factors not assessed in these studies limits the
interpretation of their results. Furthermore, these retrospective studies only analyze the out-
comes in patients with a prior diagnosis of OSA, but unlike our study did not assess which
patients with pneumonia may have OSA undiagnosed. Our case control study overcomes this
limitation and reveals a clear association between OSA and CAP.
Fig 2. Association of OSA (A) and OSA severity (B) with CAP.ORs and corresponding 95% CIs (segments) comparing the risk of CAP in (A) patients
with OSA (AHI10 vs. AHI<10) and (B) patients according to OSA severity (AHI quartiles) are shown. P-values from a logistic regression model and from a
trend test are also shown.
doi:10.1371/journal.pone.0152749.g002
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OSA is associated with upper airway inflammation and laryngeal inflammation and is corre-
lated with laryngeal sensory dysfunction and laryngeal adductor reflection attenuation [13].
Additionally, OSA is related to a weak or absent cough reflex, mainly during REM sleep [8,9], sta-
sis of the bolus after swallowing [26] and gastroesophageal reflux [10,11]. Our hypothesis is that
OSAmay be the link between abnormal AHI and silent microaspiration that causes CAP.
Together, these alterations may induce a change in the oropharyngeal microflora, producing
silent aspiration and leading to inflammatory phenomena of the lower airway. This inflammation
may trigger the systemic inflammatory factors and hypoxia-re-oxygenation that is typically
found in patients with altered AHI [27]. Finally, this succession and interrelation of events can
cause pneumonia, as we have demonstrated in our work. Aspiration during sleep, as measured
by radioactive 99mTc tracers, has been demonstrated in healthy [28] and OSA individuals [29].
However, the large quantity aspirated by OSA individuals likely contains bacterial organisms in
physiologically significant quantities. Moreover, the microbiota composition and diversity of the
intestines are altered as a result of intermittent hypoxia mimicking OSA, suggesting that physio-
logical interplays between host and gut microbiota could be deregulated in patients with OSA
[30], and this dysregulation may also contribute to the pathogenesis of pneumonia in OSA
patients. This link between OSA and infection risk should be explored to investigate the relation-
ships among gastroesophageal reflux, silent aspiration, laryngeal sensory dysfunction and CAP.
The lack of somnolence in patients with OSA and the diagnostic symptoms suggest that the
only way to diagnose OSA is by performing a sleep study. Our results confirm this suggestion.
Additionally, a previous history of CAP and the use of inhaled or oral steroids during the previ-
ous 6 months are related to a higher prevalence of current CAP.
Our study had some limitations. First, this study was conducted exclusively with patients
admitted to our hospital, and the results cannot be extrapolated to outpatients with CAP.
Table 6. Association of OSA and OSA severity with CAP severity.
PSI (n = 82) p-value
OSA
AHI <10 (non-OSA) 4937 (2984)
AHI >10 (OSA) 8395 (2630) 000002a
AHI<30 7095 (3003)
AHI >30 (severe OSA) 9043 (2858) 002a
OSA severity
AHI, quantitative scale 043 (019)* <000001b
AHI, quartiles
Q1 (AHI 0–92) 4800 (3066)
Q2 (AHI 93–141) 6724 (2656)
Q3 (AHI 142–275) 8696 (2386)
Q4 (AHI 276 or higher) 8916 (2649) 000006c
Trend p-value<000001d
The PSI was used to assess CAP severity. Two AHI-based thresholds (above 10 or 30) were used to
assess the association between OSA and CAP severity. AHI (quantitative scale and in quartiles) was used
to assess the association between OSA severity and CAP severity. Data are presented as the means (and
standard deviations).
* Pearson correlation coefﬁcients (and R-squared) are shown for AHI (quantitative scale). P-values to
assess the association with CAP severity were computed using Mann-Whitney U tests (a), Spearman’s
correlation test (b), a Kruskal-Wallis test (c) and a linear regression model (using AHI quartiles as an
ordinal variable with integer values) (d).
doi:10.1371/journal.pone.0152749.t006
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Additionally, both populations likely have an increased risk of comorbidities, which could have
caused the high prevalence of abnormal AHI in our population. However, we observed that the
prevalence of abnormal AHI in the control group was similar to this prevalence in the general
population [1]. Second, RP was performed during the admission period with supplementary
O2 in some patients when medically necessary. However, O2 administration only mildly inter-
feres with AHI calculations [31]. In addition, when RP was performed at home during the clin-
ically stable period, AHI was not significantly different.
In conclusion, OSA is associated with CAP requiring hospital admission. In addition, OSA and
OSA severity are associated with CAP severity. These results support the potential role of OSA in




Fig 3. Differences in CAP severity (PSI) according to an (A) AHI cutoff of 10 and (B) quartiles classification. Bar height represents the mean PSI
value, and the segments represent one standard deviation for each category considered.
doi:10.1371/journal.pone.0152749.g003
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S1 File. Full access to the database of this study.
(SAV)
Author Contributions
Conceived and designed the experiments: EC ML FB. Analyzed the data: EC ML FB JV EP
JNSC ALAMST. Wrote the paper: EC ML FB JV EP JNSC ALAMST. Literature search: EC
ML FB. Interpretation of the results: EC ML FB JV EP JNSC ALAMST. Data collection: JV EP
JNSC ALAMST.
References
1. Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-dis-
ordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015; 3:310–8.
doi: 10.1016/S2213-2600(15)00043-0 PMID: 25682233
2. Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F. Obstructive sleep apnoea and cardiovascular
disease. Lancet Respir Med. 2013; 1:61–72. doi: 10.1016/S2213-2600(12)70051-6 PMID: 24321805
3. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A, et al.
Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular
events in non sleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012;
307:2161–2168 doi: 10.1001/jama.2012.4366 PMID: 22618923
4. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstruc-
tive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an
observational study. Lancet. 2005; 365:1046–53 PMID: 15781100
5. Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, Duran-Cantolla J, PeñaM de L, MasdeuMJ, et al.
Association between obstructive sleep apnea and cancer incidence in a largemulticenter Spanish cohort.
Am J Respir Crit Care Med. 2013; 187:99–105 doi: 10.1164/rccm.201209-1671OCPMID: 23155146
6. Ramsey D, Smithard D, Kalra L. Silent aspiration: what do we know? Dysphagia. 2005 Summer;
20:218–25. PMID: 16362510
7. Schindler A, Mozzanica F, Sonzini G, Plebani D, Urbani E, Pecis M, et al. Oropharyngeal Dysphagia in
patients with obstructive sleep apnea syndrome. Dysphagia. 2014; 29:44–51. doi: 10.1007/s00455-
013-9474-9 PMID: 23817806
8. Murphy E, Phillipson EA. Arousal, ventilatory, and airway responses to bronchopulmonary stimulation
in sleeping dogs. J Appl Physiol 1979; 47:17–25 PMID: 224019
9. Wang HD, Nakagawa T, Sekizawa K, Kamanaka M, Sasaki H. Cough reflex in the night. Chest 1998;
114:1496–1497
10. Lindam A, Kendall BJ, Thrift AP, Macdonald GA, O'Brien S, Lagergren J, et al. Symptoms of Obstruc-
tive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett's Esophagus in a Population-
Based Case-Control Study. PLoS One. 2015; 10:e0129836 doi: 10.1371/journal.pone.0129836 PMID:
26090820
11. Konermann M, Radu HJ, Teschler H, Rawert B, Heimbucher J, Sanner BM. Interaction of sleep distur-
bances and gastroesophageal reflux in chronic laryngitis. Am J Otolaryngol 2002; 23:20–26. PMID:
11791245
12. Ravelli AM, Panarotto MB, Verdoni L, Consolati V, Bolognini S, Sullivan CE, et al. Pulmonary aspiration
shown by scintigraphy in gastroesophageal reflux-related respiratory disease. Chest. 2006; 130:1520–
6. PMID: 17099032
13. Payne RJ, Kost KM, Frenkiel S, Zeitouni AG, Sejean G, Sweet RC, et al. Laryngeal inflammation
assessed using the reflux finding score in obstructive sleep apnea. Otolaryngol Head Neck Surg 2006;
134:836–842. PMID: 16647544
14. FriedmanM, Gurpinar B, Lin HC, Schalch P, Joseph NJ. Impact of treatment of gastroesophageal reflux
on obstructive sleep apnea-hypopnea syndrome. Ann Otol Rhinol Laryngol 2007; 116:805–811. PMID:
18074664
15. Suurna MV, Welge J, Surdulescu V, Kushner J, Steward DL. Randomized placebo-controlled trial of
pantoprazole for daytime sleepiness in GERD and obstructive sleep disordered breathing. Otolaryngol
Head Neck Surg 2008; 139:286–290. doi: 10.1016/j.otohns.2008.03.012 PMID: 18656731
16. Goldbart AD, Tal A, Givon-Lavi N, Bar-Ziv J, Dagan R, Greenberg D. Sleep-disordered breathing is a
risk factor for community-acquired alveolar pneumonia in early childhood. Chest 2012; 141:1210–
1215. doi: 10.1378/chest.11-1998 PMID: 22095312
Pneumonia and Obstructive Sleep Apnea
PLOSONE | DOI:10.1371/journal.pone.0152749 April 6, 2016 12 / 13
17. Su VY, Liu CJ, Wang HK, Wu LA, Chang SC, Perng DW, et al. Sleep apnea and risk ofpneumonia: a
nation wide population-based study. CMAJ 2014; 186:415–421. doi: 10.1503/cmaj.131547 PMID:
24591276
18. Lindenauer PK, Stefan MS, Johnson KG, Priya A, Pekow PS, Rothberg MB. Prevalence, treatment,
and outcomes associated with OSA among patients hospitalized with pneumonia. Chest 2014 May;
145:1032–1038. doi: 10.1378/chest.13-1544 PMID: 24371839
19. Jean RE, Gibson CD, Jean RA, Ochieng P. Obstructive sleep apnea and acute respiratory failure: An
analysis of mortality risk in patients with pneumonia requiring invasive mechanical ventilation. J Crit
Care 2015; 30:778–783. doi: 10.1016/j.jcrc.2015.03.016 PMID: 25862071
20. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify
low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243–250. PMID:
8995086
21. Chiner E, Arriero JM, Signes-Costa J, Marco J, Fuentes I. Validation of the Spanish version of the
Epworth Sleepiness Scale in patients with a sleep apnea síndrome. Arch Bronconeumol 1999; 35:422–
427. PMID: 10596338
22. Mandell LA, Wunderink RG, Anzueto A, Barlett JG, Campbell GD, Dean NC, et al. Infectious Diseases
Society of America/American Thoracic Society consensus guidelines on the management of commu-
nity-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2: 527–572
23. Menéndez R, Torres A, Aspa J, Capelastegui A, Prat C, Rodríguez de Castro F; Sociedad Española de
Neumología y Cirugía Torácica [Community acquired pneumonia. New guidelines of the Spanish Soci-
ety of Chest Diseases and Thoracic Surgery (SEPAR)]. Arch Bronconeumol. 2010; 46:543–58. doi: 10.
1016/j.arbres.2010.06.014 PMID: 20832928
24. Santos-Silva R, Sartori DE, Truksinas V, Truksinas E, Alonso FF, Tufik S, et al. Validation of a portable
monitoring system for the diagnosis of obstructive sleep apnea syndrome. Sleep. 2009; 32:629–36.
PMID: 19480230
25. Chiner E, Signes-Costa J, Arriero JM, Gómez-Merino E, Andreu AL, Pastor E, Marco J. Validation of a
portable sleep monitoring device (Stardust1) for home studies. Am J Respir Crit Care Med 2003; 167:
A403.
26. Valbuza JS, de Oliveira MM, Zancanella E, Conti CF, Prado LB, Carvalho LB, et al. Swallowing dys-
function related to obstructive sleep apnea: a nasal fibroscopy pilot study. Sleep Breath. 2011; 15:209–
213. doi: 10.1007/s11325-010-0474-9 PMID: 21229321
27. Nacher M, Serrano-Mollar A, Farre R, Panes J, Segui J, Montserrat JM. Recurrent obstructive apneas
trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol. 2007;
155:93 PMID: 17027348
28. Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest. 1997;
111:1266–72. PMID: 9149581
29. Beal M, Chesson A, Garcia T, Caldito G, Stucker F, Nathan CO. A pilot study of quantitative aspiration
in patients with symptoms of obstructive sleep apnea: comparison to a historic control group. Laryngo-
scope. 2004; 114:965–8. PMID: 15179196
30. Moreno-Indias I, Torres M, Montserrat JM, Sanchez-Alcoholado L, Cardona F, Tinahones FJ, et al.
Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea. EurRespir J.
2015; 45:1055–6
31. Martin RJ, Sanders MH, Gray BA, Pennock BE. Acute and long-term ventilatory effects of hyperoxia in
the adult sleep apnea syndrome. Am Rev Respir Dis 1982; 125:175–180. PMID: 7065520
Pneumonia and Obstructive Sleep Apnea
PLOSONE | DOI:10.1371/journal.pone.0152749 April 6, 2016 13 / 13
